Tag: clinical trials

Risk Appetite, Tolerance and Escalation Criteria in Clinical Development

November 15, 2025November 15, 2025 digi

Risk Appetite, Tolerance and Escalation Criteria in Clinical Development In the realm of clinical development, effective risk management is paramount. Understanding risk appetite, tolerance, and escalation criteria is essential for clinical operations, regulatory affairs, and medical affairs professionals navigating the complex landscape of clinical trials. This article provides a comprehensive, step-by-step tutorial on integrating these…

Risk Assessment & Risk Controls

Visit Documentation Requirements for Remote and Home Health Visits

November 15, 2025November 15, 2025 digi

Visit Documentation Requirements for Remote and Home Health Visits In the evolving landscape of clinical trials, particularly in the wake of the global pandemic, remote and home health visits have become an essential component of clinical operations. As clinical trials increasingly embrace these models, understanding the documentation requirements for these visits is critical for regulatory…

Visit Management & Source Documentation

Linking Visit Management to Participant Experience and Retention

November 15, 2025November 15, 2025 digi

Linking Visit Management to Participant Experience and Retention Clinical trials are critical paths in the development of new therapeutics and clinical interventions. One crucial aspect of maintaining the integrity and success of clinical trials is the management of participant visits. Effective visit management directly impacts participant experience and retention rates, ultimately influencing overall trial outcomes….

Visit Management & Source Documentation

Managing GCP Risk When Working With Site Networks and SMOs

November 15, 2025November 15, 2025 digi

Managing GCP Risk When Working With Site Networks and SMOs In today’s clinical research landscape, Good Clinical Practice (GCP) compliance is essential, particularly when working with Site Management Organizations (SMOs) and site networks. As a clinical operations, regulatory affairs, or medical affairs professional, understanding the complexities of these relationships is crucial to ensuring the quality…

Sponsor & CRO GCP Obligations

Escalation Paths and Decision Rights for GCP-Critical Issues

November 15, 2025November 15, 2025 digi

Escalation Paths and Decision Rights for GCP-Critical Issues Escalation Paths and Decision Rights for GCP-Critical Issues 1. Introduction to GCP Compliance and Its Importance Good Clinical Practice (GCP) guidelines are essential in compliance with international ethical and scientific quality standards in clinical research. GCP ensures the protection of human subjects and the credibility of clinical…

Sponsor & CRO GCP Obligations

Quantitative vs Qualitative Approaches to Ranking Clinical Risks

November 15, 2025November 15, 2025 digi

Quantitative vs Qualitative Approaches to Ranking Clinical Risks In the context of clinical trials, particularly within the realms of electronic data capture in clinical trials and regulatory compliance, understanding how to evaluate and rank clinical risks is paramount. This guide provides a structured approach to navigating the quantitative and qualitative methodologies for assessing risks associated…

Risk Assessment & Risk Controls

Monitoring Source Documentation Quality: Checklists and Metrics

November 15, 2025November 15, 2025 digi

Monitoring Source Documentation Quality: Checklists and Metrics The quality of source documentation in clinical trials is paramount for ensuring the reliability of trial results and adhering to regulatory compliance. In this tutorial, we will provide a comprehensive step-by-step guide on how to effectively monitor the quality of source documentation using checklists and metrics. This is…

Visit Management & Source Documentation

Training Site Staff on Source Standards, Legibility and Corrections

November 15, 2025November 15, 2025 digi

Training Site Staff on Source Standards, Legibility and Corrections Training Site Staff on Source Standards, Legibility and Corrections Clinical trials play a critical role in the development of new treatments and therapies. Ensuring that site staff are adequately trained on source standards, legibility, and corrections is paramount for maintaining the integrity of the clinical trial…

Visit Management & Source Documentation

Global Program Governance: Study SteerCos, QMS and Quality Councils

November 15, 2025 digi

Global Program Governance: Study SteerCos, QMS and Quality Councils Global Program Governance: Study SteerCos, QMS and Quality Councils In the rapidly evolving landscape of clinical research, effective governance structure is essential for successful outcomes. Organizations engaged in the conduct of clinical trials must navigate complex regulatory environments across multiple jurisdictions while maintaining high standards of…

Sponsor & CRO GCP Obligations

Inspection Readiness for Sponsors and CROs Across Portfolios

November 15, 2025November 15, 2025 digi

Inspection Readiness for Sponsors and CROs Across Portfolios Inspection Readiness for Sponsors and CROs Across Portfolios Introduction to Inspection Readiness In the realm of clinical research, particularly in edge clinical trials, maintaining an optimal level of inspection readiness is paramount for sponsors and Contract Research Organizations (CROs). Inspection readiness entails ensuring that all processes, documentation,…

Sponsor & CRO GCP Obligations